DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1023439
Title:
In Vitro and In Vivo Activity of Omadacycline Against Two Biothreat Pathogens: Bacillus Anthracis and Yersinia Pestis
Corporate Author:
USAMRIID Frederick United States
Report Date:
2013-02-27
Abstract:
The in vitro activity and in vivo efficacy of omadacycline OMC were evaluated against the causative pathogen of anthrax and plague, Bacillus anthracis and Yersinia pestis, respectively.
Descriptive Note:
Journal Article - Open Access
Supplementary Note:
Antimicrobial Agents and Chemotherapy , 01 Jan 0001, 01 Jan 0001,
Pages:
0029
Distribution Statement:
Approved For Public Release;
File Size:
0.72MB
